February 23, 2018 | Story Review

Newsweek headline overreaches with assertion that “many more” should take antidepressants

This story also missed harms, evidence limitations, and a conflict of interest.

2 Star


February 22, 2018 | Story Review

Guardian trumpets a test to diagnose autism, but where’s the evidence?

Independent experts would have given this story important context.

1 Star

New test can detect autism in children, scientists say

February 21, 2018 | Story Review 1

CNN wrongly reports that a new blood test can “help detect concussion”

This story also missed an opportunity to point out other ways to reduce unneeded CT scans.

3 Star

FDA approves first blood test for concussion

February 19, 2018 | Story Review

ABC downplays gloomy context in reporting ‘remarkable’ BACE1 finding for Alzheimer’s

This story buoyantly reports on a finding that amyloid plaque can be reversed in mice but misses potential harms and an announcement about an aborted BACE1 trial in humans just a day earlier.

1 Star

Alzheimer's disease reversed in mice, offering hope for humans, new research shows

February 15, 2018 | Story Review

Could this be a perfect example of health news clickbait?

Far more original reporting was needed here.

2 Star

Could this experimental drug stop the flu in 24 hours?

February 14, 2018 | Story Review

A flu-killing UV lamp? TIME overreaches about the state of the science

Any research that suggests that one strain of the flu virus can be killed without side effects to humans is bound to get a lot of attention.

2 Star

This UV Lamp Could Prevent the Flu Virus From Spreading in Public Places

February 14, 2018 | Story Review

HealthDay speculates about flu-fighting abilities of UVC light

The story used speculative language from the start (“powerful” new disinfectant,” “easily kills”) and had a startling lack of information about the study.

2 Star

Shining a Deadly New Light on Airborne Flu Virus

February 8, 2018 | Story Review

Emerging migraine treatments: NPR story deftly weighs the good, the bad and the unknowns

We applaud how this story provided history, context, potential benefits but potential pitfalls (costs and side effects) of new drugs now being studied for migraine relief. Lots to like in this one.

4 Star

Gone With A Shot? Hopeful New Signs Of Relief For Migraine Sufferers

February 7, 2018 | Story Review

Disease-mongering dogs Bloomberg’s story on prostate cancer drugs

The story may also confuse readers in how it refers to “watchful waiting.” The term is most often used to describe a treatment known as active surveillance for men with slow-growing cancers. But this story applies the term to a smaller group of men with high-risk cancers who are hoping to delay recurrence and spread of the cancer.

3 Star

Early Prostate Cancer Kept at Bay in Two Studies for High-Risk Men

February 6, 2018 | Story Review

Bloomberg highlights modest weight loss benefit from standing desks study. Missing: a focus on better alternatives

Expend 54 calories by standing at your desk for 6 hours a day? There are much better ways to lose weight, none of which are mentioned here.

2 Star

Do Standing Desks Really Help You Lose Weight?


Tips for Understanding Studies

View More